GlassScriptPhysician profile
Trina Graham
NPI 1679856355
$3,220.03
in general payments reported to CMS, 2019-2025
26 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $904 · 2022: $1,497 · 2023: $270 · 2024: $242 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $409.03 | 2021-2023 | Relistor |
| Abbott Laboratories | $392.08 | 2021-2024 | Proclaim |
| Cerapedics INC. | $368.74 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Collegium Pharmaceutical, INC. | $308.64 | 2021-2023 | Xtampza |
| Horizon Therapeutics Plc | $276.73 | 2021-2022 | |
| Redhill Biopharma INC. | $246.16 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $215.61 | 2022 | |
| Scilex Pharmaceuticals INC. | $215.17 | 2021-2023 | Ztlido |
| Boston Scientific Corporation | $127.09 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Alexion Pharmaceuticals, INC. | $106.22 | 2022 | |
| Medtronic, INC. | $80.44 | 2021-2025 | Medtronic Reusable Instruments, Intellis Adaptivestim |
| Almatica Pharma LLC | $79.72 | 2021-2023 | Gralise |
| Uswm, LLC | $62.29 | 2021-2022 | |
| Vertos Medical, INC. | $42.00 | 2022-2024 | Mild Device Kit |
| Abbvie INC. | $41.55 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $41.16 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $31.46 | 2022-2023 | Seglentis |
| Pfizer INC. | $29.93 | 2021 | |
| Globus Medical, INC. | $29.10 | 2025 | Senza |
| Si-Bone, INC. | $24.51 | 2023 | |
| Acumed LLC | $20.13 | 2025 | Innate Implant, Acumed |
| Teva Pharmaceuticals USA, INC. | $15.45 | 2022 | |
| Grt US Holding, INC. | $14.58 | 2022 | |
| Azurity Pharmaceuticals, INC. | $14.57 | 2023 | Horizant |
| Sanofi-Aventis U.S. LLC | $13.86 | 2022 | |
| Ibsa Pharma INC. | $13.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trina Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.